Position in BCRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,798,390
+$264,766 QoQ
Shares Held
279,839
+5.1% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 27%
Shared 0%
None 73%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. BCRX ranks #20 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,437,213 | $103,278,126 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
120,078 | $65,061,862 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
312,832 | $52,724,705 | |
| 4 | VTRS |
Viatris Inc
|
2,872,464 | $45,614,728 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,264,159 | $31,110,952 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
633,778 | $21,973,083 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
197,060 | $21,861,836 | |
| 8 | ALKS |
Alkermes plc.
|
387,999 | $20,331,147 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,798,390 | 279,839 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,533,624 | 266,137 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,079,183 | 266,562 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,480,677 | 326,835 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,018,973 | 336,939 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,408,655 | 321,154 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,324,672 | 309,132 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,306,729 | 303,517 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,969,349 | 318,665 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,522,724 | 299,749 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,764,959 | 294,651 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,090,971 | 295,335 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,209,813 | 313,894 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,594,315 | 311,069 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,541,935 | 308,531 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,768,030 | 299,050 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,953,936 | 279,200 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,725,481 | 290,620 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,338,761 | 313,268 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,465,606 | 310,759 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,795,331 | 303,310 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,709,969 | 266,467 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,223,728 | 298,487 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $913,302 | 265,495 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,314,945 | 276,249 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $377,416 | 188,708 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||